WinstonWınston
Back
TAKE Solutions Limited logo

TAKE Solutions Limited

TAKE.NS
22
Biotechnology · Healthcare
Exchange
National Stock Exchange of India
Winston Score
22
Winston is worried
Weak fundamentals across most pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Weak
Growth
Mixed
Cash Flow
Weak
Stability
Data not available
Valuation
Mixed

Winston Score History

The full picture

TAKE Solutions Limited is an India-based company that provides technology and services to the life sciences industry, including pharmaceutical companies, biotechnology firms, and medical device makers. Its core offerings include regulatory affairs management, supply chain solutions, and clinical data services — essentially helping drug companies navigate the complex paperwork and processes required to get medicines approved and distributed. It is listed on the National Stock Exchange of India.

The company earns revenue primarily through service contracts and software licensing fees paid by its life sciences clients. TAKE Solutions operates mainly in India but also serves clients in the United States, Europe, and other regulated markets. Its competitive position relies on deep expertise in regulatory compliance, which is difficult to replicate quickly. However, the company's negative gross and operating margins signal that it is currently spending more than it earns, and returning to profitability is the central challenge the business must address to remain viable long-term.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
0.1%
Thin — 0.1% gross margin
Profit after running costs
Operating Margin
-0.9%
Losing money on operations — -0.9%
Return on the money invested
ROCE
-5.6%
Weak — -5.6% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
Data not available
Profit growth
EPS YoY
-68.6%
Earnings shrinking (-68.6% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
-24%
Weak — only -24% of profit becomes cash
Spare cash per sale
FCF Margin
-3.7%
Burning cash (-3.7%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
25.5x
no trend
Growth-priced — P/E 25.5

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial